Page last updated: 2024-11-04

sulfamethazine and Scleroderma, Systemic

sulfamethazine has been researched along with Scleroderma, Systemic in 1 studies

Sulfamethazine: A sulfanilamide anti-infective agent. It has a spectrum of antimicrobial action similar to other sulfonamides.
sulfamethazine : A sulfonamide consisting of pyrimidine with methyl substituents at the 4- and 6-positions and a 4-aminobenzenesulfonamido group at the 2-position.

Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ermakova, TM1
Kovaleva, VL1
Brezhneva, EG1
Evstaf'eva, OL1
Alekseev, IuV1

Other Studies

1 other study available for sulfamethazine and Scleroderma, Systemic

ArticleYear
[Clinical evaluation of N-acetyltransferase activity in children with various forms of diffuse connective tissue diseases].
    Pediatriia, 1983, Issue:11

    Topics: Acetylation; Acetyltransferases; Adolescent; Child; Dermatomyositis; Humans; Lupus Erythematosus, Sy

1983